多分次放射外科治疗视路周围脑膜瘤:CyberKnife协作研究中长期结果
中位随访51个月,3年、5年、8年无进展生存率分别为98%、94%、90%,排除进展患者后视力恶化率为3.7%,治疗前有视力缺损者中42%视力改善。结论认为该方案有效控制肿瘤并保护视功能。
要点
- 25 Gy分5次方案适用于无法单次放射外科的视路周围颅底脑膜瘤。
- 中位随访51个月,5年无进展生存率94%,8年90%。
- 排除进展患者后视力恶化率3.7%,42%治疗前视力缺损者改善。
核心结论
- 25 Gy分5次连续5天是多分次放射外科治疗靠近前视路或体积过大无法单次放射外科的脑膜瘤的有效方案,可控制肿瘤并保护视功能。
主要发现
- 中位随访51个月(范围36-129个月),3年、5年、8年无进展生存率分别为98%、94%、90%。
- 排除进展患者后,视力恶化率为3.7%。
- 治疗前存在视力缺损的患者中,42%视力改善。
关键数值与推荐
- 治疗方案为25 Gy分5次,连续5天给予。
临床怎么用
- 对于靠近前视路或体积过大不适合单次放射外科的颅底脑膜瘤,可考虑25 Gy分5次的多分次放射外科方案。
- 治疗决策需结合肿瘤体积、与前视路的距离及既往手术史综合评估。
局限性
- 回顾性研究设计。
- 仅纳入随访至少36个月的患者。
- 多中心数据,可能存在选择偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Most recent literature has confirmed the efficacy of single-session radiosurgery (sRS) in the treatment of intracranial meningioma. Unfortunately, sRS is not always applicable due to large tumor volume and the proximity of the tumor to critical structures. When sRS is not recommended, multi-session radiosurgery (mRS) can be the solution. The best treatment schedule for mRS, however, is not well established. The aim of the present retrospective study is to validate the effectiveness of one approach, 25 Gy delivered in 5 fractions in 5 consecutive days, to treat skull base meningiomas. METHODS: This is a retrospective multicenter study. Patients with an anterior or a medium skull base meningioma that could not be treated by sRS due to large volume or proximity to the anterior optic pathways (AOPs) underwent 5-fraction mRS. Only patients with at least 36 months follow-up were included in the analysis. Local control and visual outcomes were investigated. RESULTS: One-hundred-sixty-seven patients were included in the analysis. One-hundred-one patients underwent RS as a primary indication and 66 were treated after a previous surgery. The median follow-up period was 51 months (range 36-129 months). Progression-free survival at 3, 5 and 8 years were, respectively, 98%, 94% and 90%. Excluding the progressive disease patients, the visual worsening rate was 3.7%. The 42% of the patients with a pre-treatment visual deficit experienced improvement in vision. CONCLUSION: 25 Gy delivered in 5 fractions is an effective modality for meningiomas that are near the AOP or are too large to be treated by sRS. The treatment schedule controlled the tumors while sparing visual function.
引用
- Marchetti M, Conti A, Beltramo G, et al. Multisession radiosurgery for perioptic meningiomas: medium-to-long term results from a CyberKnife cooperative study. J Neurooncol. 2019. PMID: 31119480. doi:10.1007/s11060-019-03196-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。